Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

461 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Asthma control in severe asthmatics under treatment with omalizumab: a cross-sectional observational study in Italy.
Novelli F, Latorre M, Vergura L, Caiaffa MF, Camiciottoli G, Guarnieri G, Matucci A, Macchia L, Vianello A, Vultaggio A, Celi A, Cazzola M, Paggiaro P; Xolair Italian Study Group. Novelli F, et al. Among authors: guarnieri g. Pulm Pharmacol Ther. 2015 Apr;31:123-9. doi: 10.1016/j.pupt.2014.09.007. Epub 2014 Sep 30. Pulm Pharmacol Ther. 2015. PMID: 25281265
Drop-out rate among patients treated with omalizumab for severe asthma: Literature review and real-life experience.
Caminati M, Senna G, Stefanizzi G, Bellamoli R, Longhi S, Chieco-Bianchi F, Guarnieri G, Tognella S, Olivieri M, Micheletto C, Festi G, Bertocco E, Mazza M, Rossi A, Vianello A; North East Omalizumab Network study group. Caminati M, et al. Among authors: guarnieri g. BMC Pulm Med. 2016 Aug 25;16(1):128. doi: 10.1186/s12890-016-0290-5. BMC Pulm Med. 2016. PMID: 27562427 Free PMC article. Review.
Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life Perspective.
Caminati M, Vianello A, Chieco Bianchi F, Festi G, Guarnieri G, Marchi MR, Micheletto C, Olivieri M, Tognella S, Guerriero M, Senna G; NEONET Study Group. Caminati M, et al. Among authors: guarnieri g. J Investig Allergol Clin Immunol. 2020;30(1):35-41. doi: 10.18176/jiaci.0379. Epub 2019 Jan 24. J Investig Allergol Clin Immunol. 2020. PMID: 30676321 Free article.
Higher blood eosinophil levels after omalizumab treatment may be associated with poorer asthma outcomes.
Sposato B, Scalese M, Milanese M, Masieri S, Cavaliere C, Latorre M, Scichilone N, Ricci A, Cresti A, Santus P, Olivieri C, Perrella A, Rogliani P, Paggiaro P; Omalizumab Italian Study Group. Sposato B, et al. J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1643-1646. doi: 10.1016/j.jaip.2019.03.006. Epub 2019 Mar 19. J Allergy Clin Immunol Pract. 2019. PMID: 30898690 No abstract available.
Characteristics and treatment regimens across ERS SHARP severe asthma registries.
van Bragt JJMH, Adcock IM, Bel EHD, Braunstahl GJ, Ten Brinke A, Busby J, Canonica GW, Cao H, Chung KF, Csoma Z, Dahlén B, Davin E, Hansen S, Heffler E, Horvath I, Korn S, Kots M, Kuna P, Kwon N, Louis R, Plaza V, Porsbjerg C, Ramos-Barbon D, Richards LB, Škrgat S, Sont JK, Vijverberg SJH, Weersink EJM, Yasinska V, Wagers SS, Djukanovic R, Maitland-van der Zee AH; SHARP Clinical Research Collaboration; Members of the SHARP Clinical Research Collaboration are. van Bragt JJMH, et al. Eur Respir J. 2020 Jan 9;55(1):1901163. doi: 10.1183/13993003.01163-2019. Print 2020 Jan. Eur Respir J. 2020. PMID: 31601713 Free article.
COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: Results from a multicenter Italian survey.
Matucci A, Caminati M, Vivarelli E, Vianello A, Micheletto C, Menzella F, Crisafulli E, Passalacqua G, Bagnasco D, Lombardi C, Parronchi P, Crivellaro MA, Chieco-Bianchi F, Rita Marchi M, Guarnieri G, Cosmi L, Rossi O, Almerigogna F, Senna G, Vultaggio A. Matucci A, et al. Among authors: guarnieri g. Allergy. 2021 Mar;76(3):871-874. doi: 10.1111/all.14516. Epub 2020 Aug 11. Allergy. 2021. PMID: 32716580 No abstract available.
461 results